Page 3 - Co Diagnostics News Today

Co-Diagnostics (NASDAQ:CODX – Free Report) and CellaVision AB (publ) (OTCMKTS:CLVSF – Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Analyst Recommendations This is a breakdown of current recommendations for […]

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a large decrease in short interest in the month of May. As of May 31st, there was short interest totalling 598,800 shares, a decrease of 17.2% from the May 15th total of 723,400 shares. Based on an average daily volume of 143,500 shares, the short-interest ratio is presently […]

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) – Stock analysts at HC Wainwright boosted their Q2 2023 earnings estimates for shares of Co-Diagnostics in a report issued on Monday, May 15th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings per share of ($0.24) for the quarter, up from their prior forecast […]

/PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) was the target of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 857,900 shares, a drop of 19.8% from the March 31st total of 1,070,000 shares. Based on an average daily volume of 142,600 shares, the short-interest […]

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating)’s share price fell 4% on Friday . The stock traded as low as $1.45 and last traded at $1.45. 64,562 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 135,768 shares. The stock had previously closed at $1.51. Analysts Set New Price […]

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 20.6% from the February 28th total of 1,310,000 shares. Based on an average trading volume of 135,600 shares, the days-to-cover […]

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 20.6% from the February 28th total of 1,310,000 shares. Based on an average daily trading volume, of 135,600 shares, the short-interest ratio is […]